GlaxoSmithKline PLC ADR (GSK) — Cash Flow Reinvestment Rate
GlaxoSmithKline PLC ADR (GSK) has a Cash Flow Reinvestment Rate of 0.13x as of June 2026, reinvesting $328.95 Million (capex $328.95 Million ) from operating cash flow of $2.54 Billion. See GSK free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline PLC ADR Cash Flow Reinvestment Rate (1990–2025)
Historical reinvestment intensity for GlaxoSmithKline PLC ADR across 36 annual periods. For the full cash flow conversion analysis, see GSK cash generation efficiency.
Annual Cash Flow Reinvestment Rate for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year capital reinvestment analysis for GlaxoSmithKline PLC ADR. See GSK FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $1.33 Billion | $7.14 Billion | $1.32 Billion | ▼ -71.0% |
| 2024 | 0.64x | $4.21 Billion | $6.55 Billion | $2.98 Billion | ▲ +57.0% |
| 2023 | 0.41x | $3.23 Billion | $7.89 Billion | $1.63 Billion | ▼ -72.5% |
| 2022 | 1.49x | $11.03 Billion | $7.40 Billion | $2.26 Billion | ▲ +262.9% |
| 2021 | 0.41x | $3.27 Billion | $7.95 Billion | $2.93 Billion | ▼ -21.2% |
| 2020 | 0.52x | $4.40 Billion | $8.44 Billion | $2.24 Billion | ▼ -44.4% |
| 2019 | 0.94x | $7.52 Billion | $8.02 Billion | $2.16 Billion | ▲ +135.7% |
| 2018 | 0.40x | $3.35 Billion | $8.42 Billion | $1.80 Billion | ▼ -24.5% |
| 2017 | 0.53x | $3.65 Billion | $6.92 Billion | $2.20 Billion | ▼ -5.5% |
| 2016 | 0.56x | $3.62 Billion | $6.50 Billion | $2.35 Billion | ▼ -86.1% |
| 2015 | 4.02x | $10.32 Billion | $2.57 Billion | $1.90 Billion | ▲ +1013.8% |
| 2014 | 0.36x | $1.87 Billion | $5.18 Billion | $1.75 Billion | ▲ +26.2% |
| 2013 | 0.29x | $2.06 Billion | $7.22 Billion | $1.70 Billion | ▼ -17.8% |
| 2012 | 0.35x | $1.52 Billion | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $1.33 Billion | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $1.64 Billion | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $1.87 Billion | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $2.07 Billion | $7.31 Billion | $2.07 Billion | ▼ -18.6% |
| 2007 | 0.35x | $2.14 Billion | $6.17 Billion | $2.14 Billion | ▼ -10.9% |
| 2006 | 0.39x | $1.59 Billion | $4.08 Billion | $1.59 Billion | ▲ +104.6% |
| 2005 | 0.19x | $1.18 Billion | $6.20 Billion | $1.18 Billion | ▲ +269.3% |
| 2004 | 0.05x | $255.00 Million | $4.94 Billion | $255.00 Million | ▼ -76.4% |
| 2003 | 0.22x | $1.06 Billion | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $1.23 Billion | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $1.12 Billion | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.10 Billion | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $597.00 Million | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $475.00 Million | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $415.00 Million | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $401.00 Million | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $684.00 Million | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $485.59 Million | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $575.00 Million | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $608.00 Million | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $594.00 Million | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $606.00 Million | $615.00 Million | $606.00 Million | — |